Gynecologic Health Across the Lifespan: Systemic Pathways and Long-Term Clinical Outcomes
DOI:
https://doi.org/10.64784/119Palabras clave:
Gynecologic health, life-course approach, menopause, polycystic ovary syndrome, endometriosis, cardiovascular risk, metabolic health, hormone therapy, women’s healthResumen
Gynecologic health has traditionally been approached through a reproductive-centered lens; however, growing international evidence demonstrates that gynecologic conditions, hormonal transitions, and interventions exert significant systemic and long-term clinical effects across the female lifespan. This narrative review synthesizes high-impact literature addressing gynecologic health beyond reproductive function, with particular emphasis on metabolic, cardiovascular, endocrine, immune-inflammatory, genitourinary, and oncologic outcomes. Chronic conditions such as polycystic ovary syndrome and endometriosis are examined as early and midlife determinants of long-term systemic risk, while menopause is analyzed as a critical biological transition influencing cardiometabolic health. The review also explores the long-term implications of gynecologic surgery, hormonal contraception, and menopausal hormone therapy, highlighting the complexity and context-dependence of associated risks and benefits. By adopting a life-course and systems-based perspective, this article underscores the importance of integrating gynecologic history into comprehensive risk assessment, preventive strategies, and medical education. The findings support a reframing of gynecology as a foundational component of women’s overall health, with relevance across diverse healthcare settings, including Mexico, Colombia, and Ecuador.
Referencias
• Azziz, R., Carmina, E., Chen, Z., Dunaif, A., Laven, J. S. E., Legro, R. S., & Yildiz, B. O. (2016). Polycystic ovary syndrome. Nature Reviews Disease Primers, 2, 16057. https://doi.org/10.1038/nrdp.2016.57
• Beral, V., Million Women Study Collaborators. (2003). Breast cancer and hormone-replacement therapy in the Million Women Study. The Lancet, 362(9382), 419–427. https://doi.org/10.1016/S0140-6736(03)14065-2
• Carr, M. C. (2003). The emergence of the metabolic syndrome with menopause. Journal of Clinical Endocrinology & Metabolism, 88(6), 2404–2411. https://doi.org/10.1210/jc.2003-030242
• Davis, S. R., Lambrinoudaki, I., Lumsden, M., Mishra, G. D., Pal, L., Rees, M., Santoro, N., & Simoncini, T. (2015). Menopause. Nature Reviews Disease Primers, 1, 15004. https://doi.org/10.1038/nrdp.2015.4
• Faubion, S. S., Larkin, L. C., Stuenkel, C. A., Bachmann, G. A., Chism, L. A., Kaunitz, A. M., … Shifren, J. L. (2015). Management of genitourinary syndrome of menopause. Mayo Clinic Proceedings, 90(9), 1234–1248. https://doi.org/10.1016/j.mayocp.2015.06.013
• Gao, Y., Zhang, W., Wang, Y., & Deng, X. (2019). Endometriosis and cardiovascular disease: A systematic review. Reproductive Sciences, 26(10), 1341–1351. https://doi.org/10.1177/1933719118821183
• Gibson, D. A., & Saunders, P. T. K. (2014). Endometriosis and the immune system. Human Reproduction Update, 20(5), 748–764. https://doi.org/10.1093/humupd/dmu021
• Hickey, M., Elliott, J., & Davison, S. L. (2012). Hormone replacement therapy. BMJ, 344, e763. https://doi.org/10.1136/bmj.e763
• Ingelsson, E., Lundholm, C., Johansson, A. L. V., & Altman, D. (2011). Hysterectomy and risk of cardiovascular disease. European Heart Journal, 32(6), 745–750. https://doi.org/10.1093/eurheartj/ehq477
• Løkkegaard, E., Nielsen, L. H., Keiding, N., & Lidegaard, Ø. (2012). Venous thromboembolism and hormonal contraception. BMJ, 344, e2990. https://doi.org/10.1136/bmj.e2990
• Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., … Anderson, G. L. (2013). Menopausal hormone therapy and health outcomes. JAMA, 310(13), 1353–1368. https://doi.org/10.1001/jama.2013.278040
• Nappi, R. E., & Palacios, S. (2014). Impact of vulvovaginal atrophy on sexual health. Climacteric, 17(1), 3–9. https://doi.org/10.3109/13697137.2013.871696
• Nelson, H. D. (2008). Menopause. The Lancet, 371(9614), 760–770. https://doi.org/10.1016/S0140-6736(08)60346-3
• Okoth, K., Chandan, J. S., Marshall, T., Thomas, G. N., Nirantharakumar, K., & Adderley, N. J. (2020). Association between endometriosis and risk of cardiovascular outcomes. Heart, 106(12), 921–926. https://doi.org/10.1136/heartjnl-2019-315564
• Rosenberg, L., Palmer, J. R., Wise, L. A., Horton, N. J., Adams-Campbell, L. L., & Russell, A. H. (2005). A prospective study of hysterectomy and risk of coronary heart disease. American Journal of Epidemiology, 161(10), 954–960. https://doi.org/10.1093/aje/kwi120
• Shufelt, C. L., & Merz, C. N. B. (2009). Contraceptive hormone use and cardiovascular disease. Journal of the American College of Cardiology, 53(3), 221–231. https://doi.org/10.1016/j.jacc.2008.09.042
• Somigliana, E., Vigano, P., Benaglia, L., Busnelli, A., Berlanda, N., & Vercellini, P. (2015). Endometriosis and cardiovascular risk. Human Reproduction Update, 21(4), 486–499. https://doi.org/10.1093/humupd/dmv017
• Stevenson, J. C., Hodis, H. N., Pickar, J. H., & Lobo, R. A. (2011). Coronary heart disease and menopause management. Climacteric, 14(3), 267–273. https://doi.org/10.3109/13697137.2011.558019
• Torres-de la Roche, L. A., & Ríos-Castillo, J. L. (2019). Gynecologic surgery and long-term metabolic outcomes. Journal of Women’s Health, 28(9), 1203–1210. https://doi.org/10.1089/jwh.2018.7424
• Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014). Endometriosis: Pathogenesis and treatment. Nature Reviews Endocrinology, 10(5), 261–275. https://doi.org/10.1038/nrendo.2013.255
